Seshadri T et al. |
Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. |
2006 |
Br. J. Cancer |
pmid:16570049
|
Yu J et al. |
Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. |
2003 |
Br. J. Cancer |
pmid:12771922
|
Mizunuma H et al. |
The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity. |
2003 |
Br. J. Cancer |
pmid:12771919
|
Sundar SS et al. |
Role of lymphangiogenesis in epithelial ovarian cancer. |
2006 |
Br. J. Cancer |
pmid:16685274
|
Dubois L et al. |
Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry. |
2004 |
Br. J. Cancer |
pmid:15520822
|
Cham KK et al. |
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. |
2010 |
Br. J. Cancer |
pmid:20531411
|
Tani N et al. |
Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. |
2003 |
Br. J. Cancer |
pmid:12610521
|
van Etten B et al. |
Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion. |
2003 |
Br. J. Cancer |
pmid:12610519
|
Graff BA et al. |
Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. |
2003 |
Br. J. Cancer |
pmid:12610516
|
Bocci G et al. |
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. |
2008 |
Br. J. Cancer |
pmid:18443598
|
Varani J et al. |
Vascular tube formation on matrix metalloproteinase-1-damaged collagen. |
2008 |
Br. J. Cancer |
pmid:18443597
|
Murayama T et al. |
Relation between outcomes and localisation of p-mTOR expression in gastric cancer. |
2009 |
Br. J. Cancer |
pmid:19223902
|
Miyoshi N et al. |
Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis. |
2009 |
Br. J. Cancer |
pmid:19904274
|
Yokota N et al. |
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. |
2009 |
Br. J. Cancer |
pmid:19904262
|
Sardari Nia P et al. |
Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. |
2004 |
Br. J. Cancer |
pmid:15328525
|
Offersen BV et al. |
Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. |
2002 |
Br. J. Cancer |
pmid:12454772
|
Ah-Weng A et al. |
Dermatofibrosarcoma protuberans treated by micrographic surgery. |
2002 |
Br. J. Cancer |
pmid:12454766
|
Oei AL et al. |
Surveillance of women at high risk for hereditary ovarian cancer is inefficient. |
2006 |
Br. J. Cancer |
pmid:16495917
|
Onda T et al. |
Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. |
2006 |
Br. J. Cancer |
pmid:16479256
|
Anders M et al. |
Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. |
2009 |
Br. J. Cancer |
pmid:19142187
|
Dudderidge TJ et al. |
Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. |
2007 |
Br. J. Cancer |
pmid:17406359
|
D'Arcy V et al. |
BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. |
2008 |
Br. J. Cancer |
pmid:18195709
|
Hoffman BR et al. |
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. |
2002 |
Br. J. Cancer |
pmid:12232761
|
Løvig T et al. |
Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. |
2002 |
Br. J. Cancer |
pmid:12232760
|
Mathioudaki K et al. |
The PRMT1 gene expression pattern in colon cancer. |
2008 |
Br. J. Cancer |
pmid:19078953
|
Aubele M et al. |
PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. |
2007 |
Br. J. Cancer |
pmid:17299391
|
Chiyomaru T et al. |
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. |
2010 |
Br. J. Cancer |
pmid:20160723
|
Barnes NL et al. |
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. |
2007 |
Br. J. Cancer |
pmid:17285134
|
Kaneko K et al. |
Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. |
2007 |
Br. J. Cancer |
pmid:17285122
|
Renaudin K et al. |
Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling. |
2004 |
Br. J. Cancer |
pmid:15150612
|
Wang W et al. |
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. |
2004 |
Br. J. Cancer |
pmid:15150600
|
Rennel ES et al. |
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. |
2009 |
Br. J. Cancer |
pmid:19707198
|
Carlsson J et al. |
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. |
2004 |
Br. J. Cancer |
pmid:15150568
|
Kouzu Y et al. |
Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. |
2006 |
Br. J. Cancer |
pmid:16495930
|
Kummar S et al. |
Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. |
2002 |
Br. J. Cancer |
pmid:12085180
|
Hekmatyar SK et al. |
¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice. |
2010 |
Br. J. Cancer |
pmid:20842126
|
Nakayama N et al. |
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. |
2008 |
Br. J. Cancer |
pmid:19018267
|
van Etten B et al. |
Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras. |
2002 |
Br. J. Cancer |
pmid:11875712
|
Zou M et al. |
S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. |
2005 |
Br. J. Cancer |
pmid:16265347
|
Kato T et al. |
Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. |
2007 |
Br. J. Cancer |
pmid:17923874
|
Kuefer R et al. |
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. |
2004 |
Br. J. Cancer |
pmid:14735205
|
Miyoshi A et al. |
Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. |
2004 |
Br. J. Cancer |
pmid:15026811
|
Dales JP et al. |
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). |
2004 |
Br. J. Cancer |
pmid:15026804
|
Nakayama K et al. |
Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential. |
2004 |
Br. J. Cancer |
pmid:15026802
|
Lee KT et al. |
Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. |
2004 |
Br. J. Cancer |
pmid:15026801
|
Bauer J et al. |
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. |
2009 |
Br. J. Cancer |
pmid:19654573
|
Cascinu S et al. |
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. |
2002 |
Br. J. Cancer |
pmid:11875737
|
Teh SK et al. |
Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue. |
2008 |
Br. J. Cancer |
pmid:18195711
|
Duda DG et al. |
Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis. |
2002 |
Br. J. Cancer |
pmid:11875720
|
Millis RR et al. |
Occult axillary lymph node metastases are of no prognostic significance in breast cancer. |
2002 |
Br. J. Cancer |
pmid:11875706
|
Terry G et al. |
Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions. |
2002 |
Br. J. Cancer |
pmid:11875703
|
Wang JJ et al. |
Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells. |
2003 |
Br. J. Cancer |
pmid:14612915
|
Cai H et al. |
Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. |
2004 |
Br. J. Cancer |
pmid:15316567
|
Hall JS et al. |
Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. |
2011 |
Br. J. Cancer |
pmid:21407225
|
Bing C et al. |
Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. |
2006 |
Br. J. Cancer |
pmid:17047651
|
Graham K et al. |
Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. |
2010 |
Br. J. Cancer |
pmid:20197764
|
Hori K and Saito S |
Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700). |
2004 |
Br. J. Cancer |
pmid:14735207
|
Hofer MD et al. |
Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. |
2004 |
Br. J. Cancer |
pmid:14735193
|
Terry G et al. |
The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. |
2007 |
Br. J. Cancer |
pmid:17164758
|
Hernes E et al. |
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. |
2004 |
Br. J. Cancer |
pmid:14735192
|
Kahlert C et al. |
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. |
2009 |
Br. J. Cancer |
pmid:19603023
|
Dudek AZ et al. |
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. |
2007 |
Br. J. Cancer |
pmid:17653078
|
Lee YK et al. |
BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. |
2009 |
Br. J. Cancer |
pmid:19603021
|
Yoshikawa D et al. |
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. |
2008 |
Br. J. Cancer |
pmid:18087285
|
Negri FV et al. |
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. |
2008 |
Br. J. Cancer |
pmid:18087284
|
Cheng HL et al. |
Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder. |
2005 |
Br. J. Cancer |
pmid:15870710
|
Escaff S et al. |
Study of matrix metalloproteinases and their inhibitors in prostate cancer. |
2010 |
Br. J. Cancer |
pmid:20160732
|
Myers E et al. |
A positive role for PEA3 in HER2-mediated breast tumour progression. |
2006 |
Br. J. Cancer |
pmid:17060941
|
Siriwardena BS et al. |
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. |
2006 |
Br. J. Cancer |
pmid:17060937
|
Lee JW et al. |
BRAF mutations in non-Hodgkin's lymphoma. |
2003 |
Br. J. Cancer |
pmid:14612909
|
Alain T et al. |
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro. |
2006 |
Br. J. Cancer |
pmid:17047650
|
Oehler MK et al. |
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. |
2003 |
Br. J. Cancer |
pmid:14612905
|
Campbell L et al. |
Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. |
2003 |
Br. J. Cancer |
pmid:14612902
|
Kohno Y et al. |
Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen. |
2006 |
Br. J. Cancer |
pmid:16479255
|
Reid AH et al. |
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. |
2010 |
Br. J. Cancer |
pmid:20104229
|
Taylor SE et al. |
Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approach. |
2011 |
Br. J. Cancer |
pmid:21326237
|
Shimada K et al. |
Aberrant expression of RAB1A in human tongue cancer. |
2005 |
Br. J. Cancer |
pmid:15870709
|
Almstrup K et al. |
Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. |
2005 |
Br. J. Cancer |
pmid:15856041
|
Kallio JP et al. |
Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. |
2003 |
Br. J. Cancer |
pmid:14520458
|
Moye VE et al. |
Osteopontin expression correlates with adhesive and metastatic potential in metastasis-inducing DNA-transfected rat mammary cell lines. |
2004 |
Br. J. Cancer |
pmid:15150606
|
Hata K et al. |
Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. |
2003 |
Br. J. Cancer |
pmid:14520452
|
Eves P et al. |
Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. |
2003 |
Br. J. Cancer |
pmid:14612916
|
Harada K et al. |
Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features. |
2007 |
Br. J. Cancer |
pmid:17923875
|
Dzięgiel P et al. |
Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases. |
2010 |
Br. J. Cancer |
pmid:20648017
|
Fang DD et al. |
Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. |
2010 |
Br. J. Cancer |
pmid:20332776
|
Tasaki M et al. |
ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer. |
2011 |
Br. J. Cancer |
pmid:21285982
|
Oladipo O et al. |
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. |
2011 |
Br. J. Cancer |
pmid:21285972
|
Akagi T et al. |
Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells. |
2008 |
Br. J. Cancer |
pmid:18682709
|
Gray-Schopfer VC et al. |
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? |
2006 |
Br. J. Cancer |
pmid:16880792
|
Kita Y et al. |
Expression of osteopontin in oesophageal squamous cell carcinoma. |
2006 |
Br. J. Cancer |
pmid:16880782
|
de Graeff P et al. |
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. |
2006 |
Br. J. Cancer |
pmid:16880779
|
Suzuki M et al. |
Aberrant methylation of SPARC in human lung cancers. |
2005 |
Br. J. Cancer |
pmid:15756262
|
Hsiao JR et al. |
Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. |
2003 |
Br. J. Cancer |
pmid:12865928
|
Fukushima N et al. |
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. |
2003 |
Br. J. Cancer |
pmid:12865927
|
Chang YL et al. |
Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers. |
2003 |
Br. J. Cancer |
pmid:12865924
|
Akil N et al. |
High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. |
2008 |
Br. J. Cancer |
pmid:18648363
|
Kamura S et al. |
Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. |
2010 |
Br. J. Cancer |
pmid:20606682
|
Marques AR et al. |
Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours. |
2004 |
Br. J. Cancer |
pmid:15238980
|
Okumura H et al. |
The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma. |
2005 |
Br. J. Cancer |
pmid:15655547
|
Kuroda M et al. |
The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target. |
2005 |
Br. J. Cancer |
pmid:15655544
|